TRex Bio, Inc.

NAS:TRXBHealth Technologynasdaq_composite

$14.85+0.34%LiveIn session · ≈ AED 54.54 · Market cap —

TRex Bio, Inc. · Valuation · TradingHolo

ⓘ

Valuation is not comparable for this issuer, so multiples are hidden. Use Forecasts and Financials for the underlying drivers.

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS	$20.73	+7.91%	$1.87B	—	−78.6%	—
NAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS	$30.69	−2.31%	$1.4B	—	−38.8%	+1296.0%
NAS:CTYCity Therapeutics, Inc. · 🇺🇸 NAS	$20.84	−2.89%	$1.05B	—	69.1%	—
NAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS	$12.22	+2.35%	$754.86M	—	2,275.2%	—
NAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS	$14.42	+3.82%	$658.29M	—	−40.4%	—
NAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS	$14.75	+4.17%	$468.83M	—	46.0%	—
NAS:VOGXVogenx Inc · 🇺🇸 NAS	$17.10	+7.41%	$254.02M	—	157.3%	—
NAS:CNSYCerenome, Inc. · 🇺🇸 NAS	$1.76	+6.67%	$13.36M	—	−560.2%	+168.7%
NAS:EOCNEocene Ltd. · 🇺🇸 NAS	$2.87	+0.53%	$2.98M	—	−65.3%	+102.1%
NAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS	$1.69	+9.74%	—	—	−16.8%	−67.3%